Genfit SA: Lead program Elafibranor is PPAR alpha/delta agonist in Ph 3 for NASH with data expected by 1Q20. Upcoming 2020 milestones include: NASH Fibrosis (NTZ) Ph 2 data readout, NASH combination (elafibranor + GLP-1/SGLT-2) Ph 2 POC trial initiation, PBC (elafibranor) Ph 3 trial initiation and NIS4 (IVD/biomarker) clinical commercialization initiation in partnership with Labcorp/Covance.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase III
Disease Space
Anti-inflammatory, Metabolic Disorders
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Small Molecule
Website:
Address:
245, First Street, 18th Floor
Cambridge, MA 02142
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Genfit SA

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
The Vanguard Group, Inc. 2.93 1,137,186 6.23 Funds 2020-05-31
Norges Bank Investment Management 2.41 934,721 5.12 Funds 2019-12-31
Ostrum Asset Management SA 1.15 445,000 2.44 Funds 2020-02-28
Capital Research & Management Co. (World Investors) 0.90 350,509 1.92 Funds 2020-03-31
Alken Asset Management Ltd. 0.54 208,776 1.14 Funds 2019-12-31
AXA Investment Managers UK Ltd. 0.34 130,243 0.71 Funds 2020-02-29
Syquant Capital SAS 0.31 121,438 0.67 Funds 2019-12-31
Sycomore Asset Management SA 0.31 119,566 0.66 Funds 2019-12-31
HSBC Global Asset Management (France) SA 0.31 119,020 0.65 Funds 2020-03-31
DJE Kapital AG 0.22 84,825 0.46 Funds 2020-04-30

Top 10 Holders of Genfit SA Sponsored ADR

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Millennium Management LLC 0.77 298,331 1.63 13F 2020-03-31
Capital Research & Management Co. (World Investors) 0.64 247,100 1.35 Funds 2020-03-31
Capital Research & Management Co. (International Investors) 0.64 247,100 1.35 13F 2020-03-31
Granahan Investment Management, Inc. 0.51 198,175 1.09 13F 2020-03-31
BlackRock Advisors LLC 0.34 132,623 0.73 13F 2020-03-31
Blackrock Group Ltd. (Subfiler) 0.21 80,902 0.44 13F 2020-03-31
Verition Fund Management LLC 0.09 34,970 0.19 13F 2020-03-31
Baker Bros. Advisors LP 0.07 26,696 0.15 13F 2020-03-31
Aperio Group LLC 0.05 21,333 0.12 13F 2020-03-31
BlackRock Financial Management, Inc. 0.05 18,200 0.10 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.